Work

A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Year: 2001

Type: article

Source: Neurobiology of Disease

DOI: 10.1006/nbdi.2001.0422

Authors: L.M. Refolo, M.A. Pappolla, J. LaFrancois, B. Malester, S.D. Schmidt, T. Thomas-Bryant, G.S. Tint, R. Wang, M. Mercken, S.S. Petanceska, K.E. Duff

Institutions: Nathan Kline Institute for Psychiatric Research, University of South Alabama Medical Center, University of South Alabama, University of Medicine and Dentistry of New Jersey, Rockefeller University, Janssen (Belgium)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute on Aging

Awards: G4711222612, G497741971, G5836896895, G6317463377, MUTATIONS OXIDATIVE STRESS AND AMYLOIDOGENSIS, G8971228556, G9000101552

OpenAlex ID: W2081586704

FWCI: 24.75

Cites: 49

Cited by: 521

Related to: 10